Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
Most loved Public Dish: Which One Addresses Its Nation Best? - 2Minnesota jury says Johnson & Johnson owes $65.5 million to woman with cancer who used talcum powder
- 3The 15 Most Compelling Books in History
- 4NASA’s Pandora telescope will study stars in detail to learn about the exoplanets orbiting them
- 5Home Mechanization Frameworks for Brilliant Residing
- Pick Your #1 Kind Of Treat
- Want to make America healthy again? Stop fueling climate change
- In a first, scientists observe a comet reversing its spin
- Partake in the Outside: Senior-Accommodating Exercises for 2024
- When faith comes under fire: How Iran’s repression of religious minorities has increased
- Figure out How to Function Successfully with Your Auto Collision Legal advisor for the Best Result
- Lilly becomes first healthcare firm to join trillion-dollar club, Wall Street reacts
- Historical mysteries solved by science in 2025
- Three killed as unfinished building collapses on church service in Ghana
